Co-Diagnostics, Inc. (CODX)
1.43
-0.10
(-6.84%)
USD |
NASDAQ |
Apr 07, 16:00
1.41
-0.02
(-1.40%)
After-Hours: 16:48
Co-Diagnostics EPS Diluted (Quarterly) : -12.29 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AngioDynamics, Inc. | -0.1944 |
| Precipio, Inc. | 0.2954 |
| Sera Prognostics, Inc. | -0.1577 |
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.75M |
| Revenue (Quarterly) | 0.0596M |
| Total Expenses (Quarterly) | 25.81M |
| Enterprise Value | -7.432M |
| Gross Profit Margin (Quarterly) | -587.8% |
| Profit Margin (Quarterly) | -43.20K% |
| Earnings Yield | -1.69K% |
| Normalized Earnings Yield | -1250.37 |